Characterization of gene mutations and phenotypes of cystic fibrosis in Chinese patients

Respirology

Volumn 20, Issue 2, 2015, Pages 312-318

  Liu, Yaping ^a   Wang, Lianqing ^a   Tian, Xinlun ^b   Xu, Kai Feng ^b   Xu, Wenbing ^b   Li, Xue ^b   Yue, Cai ^b   Zhang, Peng ^b   Xiao, Yi ^b   Zhang, Xue ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

CFTR; Chinese; cystic fibrosis; mutation; phenotype

Indexed keywords

CHLORIDE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA; FECES LIPID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; AZO COMPOUND; OIL SCARLET;

ADOLESCENT; ADULT; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ARTICLE; ASPERGILLUS FUMIGATUS; CAUCASIAN; CHILD; CHINESE; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DNA EXTRACTION; FEMALE; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL SYMPTOM; GENE MUTATION; GENETIC SCREENING; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INDEL MUTATION; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; SPUTUM CULTURE; SWEAT TEST; THORAX RADIOGRAPHY; YOUNG ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHEMISTRY; CHINA; FECES; GENETICS; INFANT; MUTATION; NEWBORN; PRESCHOOL CHILD; SWEAT;

ADOLESCENT; ADULT; AGE OF ONSET; ASIAN CONTINENTAL ANCESTRY GROUP; AZO COMPOUNDS; CHILD; CHILD, PRESCHOOL; CHINA; CHLORIDES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FECES; FEMALE; GENETIC TESTING; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUTATION; PHENOTYPE; SWEAT; YOUNG ADULT;

EID: 84921530690     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12452     Document Type: Article

References (29)

1. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J. Pediatr. 2008; 153: S4-14.
2. Comeau AM, Parad RB, Dorkin HL, Dovey M, Gerstle R, Haver K, Lapey A, O'Sullivan BP, Waltz DA, Zwerdling RG, et al. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics 2004; 113: 1573-1581.
3. Chen B, Zhang S, Yang Y,. The first case of CF in Mainland China identified by DNA analysis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 1995; 12: 5-9.
4. Chen HJ, Lin SP, Lee HC, Chen CP, Chiu NC, Hung HY, Chern SR, Chuang CK,. Cystic fibrosis with homozygous R553X mutation in a Taiwanese child. J. Hum. Genet. 2005; 50: 674-678.
5. Liu JR, Peng Y, Zhao YH, Wang W, Guo Y, He JX, Zhao SY, Jiang ZF,. [Clinical manifestations and gene analysis of 2 Chinese children with cystic fibrosis]. Zhonghua Er Ke Za Zhi 2012; 50: 829-833.
6. Wu CL, Shu SG, Zielenski J, Chiang CD, Tsui LC,. Novel cystic fibrosis mutation (2215insG) in two adolescent Taiwanese siblings. J. Formos. Med. Assoc. 2000; 99: 564-567.
7. Wagner JA, Vassilakis A, Yee K, Li M, Hurlock G, Krouse ME, Moss RB, Wine JJ,. Two novel mutations in a cystic fibrosis patient of Chinese origin. Hum. Genet. 1999; 104: 511-515.
8. Li N, Pei P, Bu DF, He B, Wang GF,. A novel CFTR mutation found in a Chinese patient with cystic fibrosis. Chin. Med. J. (Engl.) 2006; 119: 103-109.
9. Wang MC, Shu SG, Chang SM, Ho WL, Chi CS,. Cystic fibrosis in two Chinese infants in Taiwan. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1993; 34: 314-321.
10. Zielenski J, Markiewicz D, Lin SP, Huang FY, Yang-Feng TL, Tsui LC,. Skipping of exon 12 as a consequence of a point mutation (1898 + 5G - >T) in the cystic fibrosis transmembrane conductance regulator gene found in a consanguineous Chinese family. Clin. Genet. 1995; 47: 125-132.
11. Alper OM, Shu SG, Lee MH, Wang BT, Lo SY, Lin KL, Chiu YL, Wong LJ,. Detection of novel CFTR mutations in Taiwanese cystic fibrosis patients. J. Formos. Med. Assoc. 2003; 102: 287-291.
12. Crawford J, Labrinidis A, Carey WF, Nelson PV, Harvey JS, Morris CP,. A splicing mutation (1898 + 1G - >T) in the CFTR gene causing cystic fibrosis. Hum. Mutat. 1995; 5: 101-102.
13. Ooi CY, Dupuis A, Ellis L, Jarvi K, Martin S, Gonska T, Dorfman R, Kortan P, Solomon M, Tullis E, et al. Comparing the American and European diagnostic guidelines for cystic fibrosis: same disease, different language? Thorax 2012; 67: 618-624.
14. CLSI. Sweat Testing: Sample Collection and Quantitative Chloride Analysis; Approved Guideline-Third Edition, third edn. Clinical and Laboratory Standards Institute, Wayne, PA, 2009.
15. Knutsen AP, Slavin RG,. Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. Clin. Dev. Immunol. 2011; 2011: 1-13.
16. Drummey GD, Benson JA Jr, Jones CM,. Microscopical examination of the stool for steatorrhea. N. Engl. J. Med. 1961; 264: 85-87.
17. Li H, Ji CY, Zong XN, Zhang YQ,. [Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years]. Zhonghua Er Ke Za Zhi 2009; 47: 487-492.
18. Clancy JP, Jain M,. Personalized medicine in cystic fibrosis: dawning of a new era. Am. J. Respir. Crit. Care Med. 2012; 186: 593-597.
19. Yamashiro Y, Shimizu T, Oguchi S, Shioya T, Nagata S, Ohtsuka Y,. The estimated incidence of cystic fibrosis in Japan. J. Pediatr. Gastroenterol. Nutr. 1997; 24: 544-547.
20. Wright SW, Morton NE,. Genetic studies on cystic fibrosis in Hawaii. Am. J. Hum. Genet. 1968; 20: 157-169.
21. Romey MC, Desgeorges M, Ray P, Godard P, Demaille J, Claustres M,. Novel missense mutation in the first transmembrane segment of the CFTR gene (Q98R) identified in a male adult. Hum. Mutat. 1995; 6: 190-191.
22. Jung H, Ki CS, Koh WJ, Ahn KM, Lee SI, Kim JH, Ko JS, Seo JK, Cha SI, Lee ES, et al. Heterogeneous spectrum of CFTR gene mutations in Korean patients with cystic fibrosis. Korean J. Lab. Med. 2011; 31: 219-224.
23. Lu S, Yang X, Cui Y, Li X, Zhang H, Liu J, Chen ZJ,. Different cystic fibrosis transmembrane conductance regulator mutations in Chinese men with congenital bilateral absence of vas deferens and other acquired obstructive azoospermia. Urology 2013; 82: 824-828.
24. Li H, Wen Q, Zhao L, Zhang X, Wang J, Cheng L, Yang J, Chen S, Ma X, Wang B,. Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) in Chinese patients with congenital bilateral absence of vas deferens. J. Cyst. Fibros. 2012; 11: 316-323.
25. Ni WH, Jiang L, Fei QJ, Jin JY, Yang X, Huang XF,. The CFTR polymorphisms poly-T, TG-repeats and M470V in Chinese males with congenital bilateral absence of the vas deferens. Asian J. Androl. 2012; 14: 687-690.
26. Yu J, Chen Z, Ni Y, Li Z,. CFTR mutations in men with congenital bilateral absence of the vas deferens (CBAVD): a systemic review and meta-analysis. Hum. Reprod. 2012; 27: 25-35.
27. Bombieri C, Claustres M, De Boeck K, Derichs N, Dodge J, Girodon E, Sermet I, Schwarz M, Tzetis M, Wilschanski M, et al. Recommendations for the classification of diseases as CFTR-related disorders. J. Cyst. Fibros. 2011; 10 (Suppl. 2): S86-102.
28. Davis PB, Schluchter MD, Konstan MW,. Relation of sweat chloride concentration to severity of lung disease in cystic fibrosis. Pediatr. Pulmonol. 2004; 38: 204-209.
29. Miller PW, Hamosh A, Macek M Jr, Greenberger PA, MacLean J, Walden SM, Slavin RG, Cutting GR,. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am. J. Hum. Genet. 1996; 59: 45-51.